NGFR and Alzheimer disease: The advanced stages of early-onset and late-onset AD and psychiatric disorders (e.g., Parkinson’s disease and Lewy body dementia) are characterized by a severe loss of NGF receptor positive cholinergic cells in the basal forebrain (Mufson and Kordower, 1989; Perry, 1990).